Clinical trials recruiting for Nervous System Diseases

Phase breakdown

Drugs and treatments being studied

Where trials are recruiting (top US states)

Top cities

Self-screener

Recruiting trials

• A Multi-domain Lifestyle Intervention Among Aged Community-residents in Zhejiang, China
  NCT05886114 · Phase: Not applicable (e.g. observational or device study) · Ages: 60 Years to 80 Years · Sex: All (male and female) · 1 location
• Application of AI Technology for the Diagnosis and Treatment of Geriatric Diseases
  NCT06295263 · Phase: Not specified · Ages: 8 Years to 100 Years · Sex: All (male and female) · 1 location
• Music-4-MS to Improve Cognition in People Living With Multiple Sclerosis: A Feasibility Study
  NCT07759115 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 80 Years · Sex: All (male and female) · 1 location
• Neurologic Stem Cell Treatment Study
  NCT02795052 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 6 locations
• Non-inferiority Study of Rituximab Compared to Ocrelizumab in Relapsing MS
  NCT05834855 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Sleep Healthy Using the Internet Mitigating Insomnia to Address Neurocognitive Difficulties (SHUTi MIND)
  NCT05565833 · Phase: Phase 2 · Ages: 65 Years and older · Sex: All (male and female) · 1 location
• Slow-SPEED-NL: Slowing Parkinson's Early Through Exercise Dosage-Netherlands
  NCT06193252 · Phase: Not applicable (e.g. observational or device study) · Ages: 50 Years and older · Sex: All (male and female) · 1 location
• Slow-SPEED: Slowing Parkinson's Early Through Exercise Dosage
  NCT06993142 · Phase: Not applicable (e.g. observational or device study) · Ages: 50 Years and older · Sex: All (male and female) · 2 locations
• Slowing Cognitive Decline in Alpha-synucleinopathies by Enhancing Physical Activity
  NCT07324330 · Phase: Not applicable (e.g. observational or device study) · Ages: 50 Years to 80 Years · Sex: All (male and female) · 1 location
• Study to Evaluate the Efficacy and Safety of ATNC-MDD V1(TMS With Cognitive Training) in Mild Alzheimer's Dementia
  NCT06088121 · Phase: Not applicable (e.g. observational or device study) · Ages: 60 Years to 85 Years · Sex: All (male and female) · 11 locations
• Treating Depression on a Day-to-day Basis: Development of a Tool for Physicians Based on a Smartphone Application
  NCT03678194 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location

Related conditions

Trials recruiting for Nervous System Diseases often also study these conditions. Each links to its own recruiting-trial list.

Common questions

Are these trials free to join?

Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.

How do I know if I am eligible for Nervous System Diseases trials?

Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.

Is this list complete?

No. For the full list, search ClinicalTrials.gov.